CYduct Diagnostics, Inc.
CYDX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.39M
Close$
$-0.30
160.6% downside
Current Fair Value
160.6% downsideOvervalued by 160.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $6.39 Million |
|---|---|
| Enterprise Value | $7.09 Million |
| Earnings per Share | $-0.04 |
| Beta | -0.93 |
| Outstanding Shares | 12,783,165 |
Return
| Return on Equity | 19.66% |
|---|---|
| Return on Assets | -690.85% |
| Return on Invested Capital | 36.26% |
Valuation & Multiples
| P/E Ratio | -11.14 |
|---|---|
| PEG | 7.45 |
| Price to Sales | - |
| Price to Book Ratio | -0.5 |
| Enterprise Value to Revenue | 100.78 |
| Enterprise Value to EBIT | -45.79 |
| Enterprise Value to Net Income | -35 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | -0.67 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About CYduct Diagnostics, Inc.
3 employees
CEO: Dom L. Gatto
CYduct Diagnostics, Inc. operates as a medical instrument enterprise that engineers and commercializes a diverse range of technologies, equipment, and methodologies. These innovations are purposed for the detection, diagnosis, therapeuti...